DE69620607D1 - Trockengranulierte gepresste tabletten enthaltend desogestrel - Google Patents

Trockengranulierte gepresste tabletten enthaltend desogestrel

Info

Publication number
DE69620607D1
DE69620607D1 DE69620607T DE69620607T DE69620607D1 DE 69620607 D1 DE69620607 D1 DE 69620607D1 DE 69620607 T DE69620607 T DE 69620607T DE 69620607 T DE69620607 T DE 69620607T DE 69620607 D1 DE69620607 D1 DE 69620607D1
Authority
DE
Germany
Prior art keywords
pct
desogestrel
tablets containing
dried granulated
pressed tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69620607T
Other languages
English (en)
Other versions
DE69620607T2 (de
Inventor
Haan Pieter De
Carolus Paulus Thys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69620607D1 publication Critical patent/DE69620607D1/de
Application granted granted Critical
Publication of DE69620607T2 publication Critical patent/DE69620607T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69620607T 1995-06-22 1996-06-18 Trockengranulierte gepresste tabletten enthaltend desogestrel Expired - Fee Related DE69620607T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201698 1995-06-22
PCT/EP1996/002626 WO1997000682A1 (en) 1995-06-22 1996-06-18 Compressed dry-granulation desogestrel tablets

Publications (2)

Publication Number Publication Date
DE69620607D1 true DE69620607D1 (de) 2002-05-16
DE69620607T2 DE69620607T2 (de) 2002-09-19

Family

ID=8220405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69620607T Expired - Fee Related DE69620607T2 (de) 1995-06-22 1996-06-18 Trockengranulierte gepresste tabletten enthaltend desogestrel

Country Status (22)

Country Link
US (1) US6063403A (de)
EP (1) EP0833642B1 (de)
JP (1) JP4116672B2 (de)
KR (1) KR100421526B1 (de)
CN (1) CN1119998C (de)
AT (1) ATE215825T1 (de)
AU (1) AU710710B2 (de)
BR (1) BR9609208A (de)
CA (1) CA2224269C (de)
CZ (1) CZ289133B6 (de)
DE (1) DE69620607T2 (de)
DK (1) DK0833642T3 (de)
ES (1) ES2175106T3 (de)
HK (1) HK1008923A1 (de)
HU (1) HU223943B1 (de)
NO (1) NO316052B1 (de)
NZ (1) NZ312113A (de)
PL (1) PL184558B1 (de)
PT (1) PT833642E (de)
RU (1) RU2159618C2 (de)
TR (1) TR199701659T1 (de)
WO (1) WO1997000682A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9022098A (en) * 1997-08-20 1999-03-08 Fuisz Technologies Ltd. Process for improving flow and compression of tableting compositions
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
MX2007010638A (es) 2005-03-03 2008-03-04 Mannatech Inc Metodos y composiciones para liberacion modificada de suplementos nutritionales. t
US7771744B2 (en) * 2005-08-24 2010-08-10 Wyeth Llc Bazedoxifene acetate formulations
AU2007248613A1 (en) * 2006-05-04 2007-11-15 Novartis Ag Heated roller compaction process for making pharmaceutical compositions
KR101633939B1 (ko) * 2007-10-10 2016-06-27 아반토르 퍼포먼스 머티리얼스, 인크. 직접 압축성 고기능성 과립 미세결정 셀룰로스계 부형제, 그의 제조 방법 및 용도
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2519229A2 (de) 2009-12-29 2012-11-07 Novartis AG Neue pharmazeutische darreichungsform zur behandlung von magensäurebedingten erkrankungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
DE4222298B4 (de) * 1992-07-08 2005-11-03 Robert Bosch Gmbh Verfahren zur Dämpfung von auftretenden Ruckelschwingungen für Brennkraftmaschinen
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.

Also Published As

Publication number Publication date
CA2224269C (en) 2008-06-17
HUP9901350A2 (hu) 1999-08-30
MX9710411A (es) 1998-07-31
CN1119998C (zh) 2003-09-03
JP4116672B2 (ja) 2008-07-09
RU2159618C2 (ru) 2000-11-27
WO1997000682A1 (en) 1997-01-09
NZ312113A (en) 1998-06-26
US6063403A (en) 2000-05-16
PL184558B1 (pl) 2002-11-29
PL324345A1 (en) 1998-05-25
ES2175106T3 (es) 2002-11-16
KR19990028214A (ko) 1999-04-15
TR199701659T1 (xx) 1998-03-21
CN1188411A (zh) 1998-07-22
DK0833642T3 (da) 2002-06-10
HU223943B1 (hu) 2005-03-29
EP0833642A1 (de) 1998-04-08
CZ289133B6 (cs) 2001-11-14
AU6356696A (en) 1997-01-22
AU710710B2 (en) 1999-09-30
KR100421526B1 (ko) 2004-05-20
NO975986D0 (no) 1997-12-19
HK1008923A1 (en) 1999-05-21
NO316052B1 (no) 2003-12-08
NO975986L (no) 1997-12-19
CA2224269A1 (en) 1997-01-09
JPH11507933A (ja) 1999-07-13
PT833642E (pt) 2002-08-30
BR9609208A (pt) 1999-05-11
CZ416597A3 (cs) 1998-06-17
EP0833642B1 (de) 2002-04-10
ATE215825T1 (de) 2002-04-15
HUP9901350A3 (en) 2000-03-28
DE69620607T2 (de) 2002-09-19

Similar Documents

Publication Publication Date Title
DE69620607T2 (de) Trockengranulierte gepresste tabletten enthaltend desogestrel
NO975196L (no) Innretning for komprimering og pakking av komprimerbare produkter
MA26516A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
HUP9603433A3 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
HUP9601034A3 (en) Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them
HUP9601358A3 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
IL148195A0 (en) Methods for producing agglomerate and tablets
RU98100843A (ru) Прессованные таблетки дезогестрела, изготовленные способом сухого гранулирования
SE9502941L (sv) Förfarande vid framställning av tabletter genom pressning samt tabletter framställda enligt förfarandet
ATE173399T1 (de) Retardtablette mit einem gehalt an diclofenac-na
HUP9602748A3 (en) Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
AU9585301A (en) A compacted 2,2-dibromo-3-nitrilopropionamide
AU8010498A (en) Device for determining the decay time of compressed medicaments such as tablets and capsules, and corresponding method
DK0973509T3 (da) Multipartikulær farmaceutisk form, de udgörende partikler, fremgangsmåde og indretning til fremstilling heraf
DE69619543T2 (de) Carbonyleisen-tablette durch direktverpressung
HUP9601057A3 (en) Process for inhibiting photodecomposition of 3-substituted 2-oxindoles and pharmaceutical tablet, capsule and composition
ES2018735A6 (es) Procedimiento para la operacion de un producto potabilizador del agua.
MX9101080A (es) Metodo y triturador que emplea cilindros, para la trituracion de material quebradizo.
ZA961045B (en) New pyridil- and pyridazinyl-piperazine derivates, process for the production thereof and pharmaceutical agents containing these compounds.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

8339 Ceased/non-payment of the annual fee